Introduction to Mitochondrial Disease - Non CME

Course•By Mitochondrial Medicine Society

Non CME - Cardiac Management In Mitochondrial Disease

Mitochondrial Disease and Specialties - Part 1

Course•By Hilary Vernon, MD, PhD

Non CME - Endocrinology and Mitochondrial Disease

Course•By Shana McCormack, MD, MTR

Non CME - Management of Acute Emergencies (ICU) in Primary Mitochondrial Disease

Course•By Amy Goldstein, MD and Rebecca Ganetzky, MD

Non CME - Mitochondrial Hearing Loss

Mitochondrial Disease and Specialties - Part 2

Course•By Peter Kullar, MRCS, PhD

Non CME - Nephrology and Mitochondrial Disease

Mitochondrial Disease and Specialties - Part 1

Course•By Rebecca Ganetzky, MD

Non CME - Neuromuscular Features in Mitochondrial Diseases

Mitochondrial Disease and Specialties - Part 2

Course•By Michelangelo Mancuso, MD, PhD

Non CME - Ophthalmic Manifestations of Mitochondrial Diseases

Mitochondrial Disease and Specialties - Part 2

Course•By Jane H. Lock, MBBS, MMed, FRANZCO

UMDF Mitochondrial Medicine 2023 - Mito Genetic Therapy - Course 6

Step Toward Treatment of Mito Cardiomyopathy; mtDNA Gene Editing; mtDNA & Deaminases

Course•By Mito Med 2023 Course 6 Speakers

UMDF Mitochondrial Medicine 2023 - Mito Inflammation - Course 1

Mitonuclear Signaling; PINK1- and Parkin-mediated Mitophagy & links to Inflammation & Neurodegeneration; Extracellular ATP Signaling, Inflammation, & Mitochondrial Dysfunction; Are Patients with Mitochondrial Diseases Hypermetabolic?

Course•By Mito Med 2023 Course 1 Speakers

UMDF Mitochondrial Medicine 2023 - Mito Transfer/Fatty Acid Synthesis - Course 7

Vesicular Transfer; Nanotube Transfer; Mito Transfer & Leigh Syndrome; Mito Transplantation; mtFASII Pathway & Mouse Model; Mito FASII in OXPHOS; Small Molecule Therapy

Course•By Mito Med 2023 Course 7 Speakers

UMDF Mitochondrial Medicine 2023 - Mitochondria/Viruses - Course 3

Mitochondrion and Immune System; Viral Exposures in Mito; Mito Dysfunction and COVID-19; Post-Acute Sequelae of COVID-19; Coronaviruses; Flaviviruses; Mito Disease & Viral Exposure; Connections Between Viral Exposome & Mito

Course•By Mito Med 2023 Course 3 Speakers

UMDF Mitochondrial Medicine 2023 - Mitochondrial Signaling - Course 4

Mito & Cellular Metabolism; mtDNA Conformation Regulation; MNRR1 Bicompartmental Mito Regulation; MAT (Mito Augmentation Therapy and MEPAN;

Course•By Mito Med 2023 Course 4 Speakers

UMDF Mitochondrial Medicine 2023 - Mysteries of mtDNA - Course 2

Mito-DNA Encoded Microproteins; mtDNA Transcription Factor Binding; Stem Cells, Organoids & Imaging; mtDNA Haplogroup Disease Associations

Course•By Mito Med 2023 Course 2 Speakers

UMDF Mitochondrial Medicine 2024 - Advances in Disease Models for Investigating Mitochondrial Diseases - Course 1

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids

Course•By Mito Med 2024 Speakers

UMDF Mitochondrial Medicine 2024 - Development of Improved Outcome Measures for Mitochondrial Clinical Trials - Course 4

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids

Course•By Mito Med 2024 Speakers

UMDF Mitochondrial Medicine 2024 - Disorders of Mitochondrial DNA Integrity - Course 3

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids

Course•By Mito Med 2024 Speakers

UMDF Mitochondrial Medicine 2024 - Mitochondria and Metabolic Plasticity - Course 2

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids

Course•By Mito Med 2024 Speakers

UMDF Mitochondrial Medicine 2024 - Mitochondrial Dysfunction and its Impact on Mental Health - Course 6

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids

Course•By Mito Med 2024 Speakers

UMDF Mitochondrial Medicine 2024 - Therapeutic Development for Mitochondrial Disease: Lessons learned from other Rare Diseases - Course 7

Mitochondrial Double-Stranded RNA as a New DAMP to Activate the Immune Response in Mitochondrial Disease; Development of Cortical Organoids to Model m.3243A>G Disease and Understand Cell Specificity; The Distribution and Functional Impact of MELAS Mutation m.3243A>G in Cardiac Cells, and Novel Approaches to Restore Cellular Dysfunction; Induced Pluripotent Stem Cell Based Cardiac Model of MELAS Disease; Modeling Diabetes in MELAS Disease Using Induced Pluripotent Stem Cell Based Parectatic Organoids

Course•By Mito Med 2024 Speakers